Supervisory board of AS “Citadele banka” appoints Johan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
455
Supervisory board of AS “Citadele banka” appoints Johan Akerblom as Chief Financial Officer

The Supervisory Board of AS “Citadele banka” has approved Johan Akerblom as a Chief Financial Officer of the Bank. J. Akerblom will become elected in Bank’s Management Board once the approval of Financial and Capital Market Commission will be received. Johan Akerblom is expected to begin his duties as of February 1, 2018.

With 10 years of experience in the financial sector, Johan Akerblom has spent the previous two years as Chief Financial Officer for the Baltic division at SEB Group. Prior to that, Mr. Akerblom worked for SEB Group’s German subsidiary as Chief Financial Officer starting in 2014. Before that he was responsible for Business Development and Controlling at SEB Group’s German subsidiary. Mr. Akerblom joined SEB in 2008 working in the CFO office in Sweden. Before joining SEB, he worked in Sweden for ISS Facility Services and McKinsey & Company.

Johan Akerblom holds a master’s degree in industrial management and engineering from the Lund Institution of Technology; in addition, he was a scholarship nominee for McGill University in Montreal, Canada.

Johan Akerblom does not hold shares of AS “Citadele banka.”

The Chairman of the Citadele Board is Guntis Beļavskis, and the Board is represented by its members– Santa Purgaile, Kaspars Cikmačs, Valters Ābele, Uldis Upenieks, Slavomir Mizak un Vladislavs Mironovs.

Citadele is the third largest bank in Latvia by number of clients. The Citadele Group is managed from Latvia, and its subsidiaries and branches operate in Latvia, Lithuania, Estonia and Switzerland.

Further information:

Baiba Ābelniece

Head of External Communications

Telephone: +371 67010326; +371 26624221

E-mail: baiba.abelniece@citadele.lv

Mihails Golevs

Head of Financial Institutions

Telephone: +371 67778585

E-mail: mihails.golevs@citadele.lv

Santa Daniela Kanaška

Investor relations specialist

Telephone: +371 67010991

E-mail: IR@citadele.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 280

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Emerging Markets Surge Ahead with Historic Bond Sales Strategy

Updated Category News Views 241

Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...

Continue Reading
Multi Ways Holdings Reflects on Fiscal Year 2024 Performance

Updated Category News Views 167

Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...

Continue Reading
Neurocrine Adjusts Course Following Luvadaxistat Study Setback

Updated Category News Views 117

Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...

Continue Reading
Rinnai America Leads Coalition Against DOE Water Heater Rule

Updated Category News Views 294

Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...

Continue Reading